Myriad Genetics News and Activities

Presence

Myriad Genetics develops genetic tests and related diagnostic services for disease risk, cancer care, and treatment decisions. It serves hospitals, doctors, laboratories, and patients in the United States and other healthcare markets.

Myriad Genetics products and services overview:

Genetic testing
Cancer diagnostics
Prenatal screening
Risk assessment
Laboratory services

Revenue: ~$836 million

Employees: 2,700

Headquarters: Salt Lake City, United States (USA)

Myriad Genetics is one of the...

Myriad Genetics is a company listed under the stock ticker MYGN (US).

Myriad Genetics has a direct presence in 2 countries.

They are in:

Executives

View the org chart displaying its 29 main executives

Most searched biographies at Myriad Genetics

Popular executive movements at Myriad Genetics

Raj Jampa has joined the company as Chief Technology Officer (posted on June 2 2026).
Kevin Haas, Chief Technology Officer, will leave the company on Mar. 24, 2026 (posted on March 17 2026).

Create your alert
to follow the executive moves at Myriad Genetics.